In recent years, β2 arrestins have been shown to be involved with regulation of insulin action and inflammatory signal pathway, particularly in type 2 diabetes [25], and thus could be of interest as regulators of insulin sensitivity in CF. The gene discussed is INS; the disease is type 2 diabetes mellitus.